Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA Cancer J Clin. 2025;75:10–45.
Google Scholar
DeSantis CE, Ma J, Gaudet MM, Newman LA, Miller KD, Goding Sauer A, et al. Breast cancer statistics, 2019. CA Cancer J Clin. 2019;69:438–51.
Google Scholar
Eaglehouse YL, Georg MW, Shriver CD, Zhu K. Racial differences in time to breast cancer surgery and overall survival in the US Military Health System. JAMA Surg. 2019;154:e185113.
Google Scholar
Wiener AA, Hanlon BM, Schumacher JR, Vande Walle KA, Wilke LG, Neuman HB. Reexamining time from breast cancer diagnosis to primary breast surgery. JAMA Surg. 2023;158:485–92.
Google Scholar
Sheppard VB, Oppong BA, Hampton R, Snead F, Horton S, Hirpa F, et al. Disparities in breast cancer surgery delay: the lingering effect of race. Ann Surg Oncol. 2015;22:2902–11.
Google Scholar
DeGroff A, Royalty JE, Howe W, Buckman DW, Gardner J, Poister T, et al. When performance management works: a study of the National Breast and Cervical. Cancer Early Detect Program Cancer. 2014;120:2566–74.
Google Scholar
Yancy B, Royalty JE, Marroulis S, Mattingly C, Benard VB, DeGroff A. Using data to effectively manage a national screening program. Cancer. 2014;120:2575–83.
Google Scholar
George P, Chandwani S, Gabel M, Ambrosone CB, Rhoads G, Bandera EV, et al. Diagnosis and surgical delays in African American and white women with early-stage breast cancer. J Women’s Health. 2015;24:209–17.
Google Scholar
Gehlert S, Hudson D, Sacks T. A critical theoretical approach to cancer disparities: breast cancer and the social determinants of health. Front Public Health. 2021;9:674736.
Google Scholar
Venkataramany BS, Sutton JM. Social determinants of health in oncology: towards a more personalized and equitable delivery of cancer care. Am J Clin Oncol. 2022;45:273–8.
Google Scholar
INSIGHT Clinical Research Network. https://insightcrn.org/our-data/.
Kaushal R, Hripcsak G, Ascheim DD, Bloom T, Campion TR Jr., Caplan AL, et al. Changing the research landscape: the New York City Clinical Data Research Network. J Am Med Inf Assoc. 2014;21:587–90.
Google Scholar
Shang N, Hripcsak G, Weng C, Chung W, Crew KA. KnowledgeBase for Discovering Phenotypes from Electronic Medical Records – Breast Cancer 2019.
Comorbidity SAS Macro (2021 version). National Cancer Institute, Division of Cancer Control & Population Sciences 2021.
Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83.
Google Scholar
U.S. Department of Health and Human Services, Office of Disease Prevention and Health Promotion. Social Determinants of Health. Healthy People 2030. Available at: https://health.gov/healthypeople/objectives-and-data/social-determinants-health (Accessed October 2025).
Fox J, Monette G. Generalized collinearity diagnostics. J Am Stat Assoc. 1992;87:178–83.
Google Scholar
National Cancer Institute, Division of Cancer Control and Population Sciences, Joinpoint Trend Analysis Software 2025.
Zipkin RJ, Schaefer A, Wang C, Loehrer AP, Kapadia NS, Brooks GA, et al. Rural-urban differences in breast cancer surgical delays in medicare beneficiaries. Ann Surg Oncol. 2022;29:5759–69.
Google Scholar
Emerson MA, Golightly YM, Aiello AE, Reeder-Hayes KE, Tan X, Maduekwe U, et al. Breast cancer treatment delays by socioeconomic and health care access latent classes in Black and White women. Cancer. 2020;126:4957–66.
Google Scholar
Chen Y-W, Kim T, Specht MC, Gadd MA, Smith BL, Chang DC, et al. Time to surgery: a health equity metric in breast cancer patients. Am J Surg. 2023;226:432–7.
Google Scholar
Bleicher RJ, Ruth K, Sigurdson ER, Beck JR, Ross E, Wong YN, et al. Time to surgery and breast cancer survival in the United States. JAMA Oncol. 2016;2:330–9.
Google Scholar
Giordano SH, Franzoi MAB, Temin S, Anders CK, Chandarlapaty S, Crews JR, et al. Systemic therapy for advanced human epidermal growth factor receptor 2-positive breast cancer: ASCO guideline update. J Clin Oncol. 2022;40:2612–35.
Google Scholar
Partridge AH, Rumble RB, Carey LA, Come SE, Davidson NE, Di Leo A, et al. Chemotherapy and targeted therapy for women with human epidermal growth factor receptor 2-negative (or unknown) advanced breast cancer: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2014;32:3307–29.
Google Scholar
Zhu K, Yang X, Tai H, Zhong X, Luo T, Zheng H. HER2-targeted therapies in cancer: a systematic review. Biomark Res. 2024;12:16.
Google Scholar
Siegel E, Tseng J, Giuliano A, Amersi F, Alban RF. Treatment at academic centers increases likelihood of reconstruction after mastectomy for breast cancer patients. J Surg Res. 2020;247:156–62.
Google Scholar
Tseng WH, Stevenson TR, Canter RJ, Chen SL, Khatri VP, Bold RJ, et al. Sacramento area breast cancer epidemiology study: use of postmastectomy breast reconstruction along the rural-to-urban continuum. Plast Reconstr Surg. 2010;126:1815–24.
Google Scholar
Corey KM, Helmkamp J, Simons M, Curtis L, Marsolo K, Balu S, et al. Assessing quality of surgical real-world data from an automated electronic health record pipeline. J Am Coll Surg. 2020;230:295–305.e12.
Google Scholar
Martin G, Kensler KH, An A, Gemson E, Mount L, Tamimi RM, et al. Closing the gap: disparities in breast reconstruction after mastectomy. Ann Surg Oncol. 2025;32:8313–22.
Google Scholar
